Crossmark

A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers

Crossref DOI link: https://doi.org/10.1007/s11523-017-0525-2

Published Online: 2017-08-10

Published Print: 2017-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Escudier, Bernard

Faivre, Sandrine

Van Cutsem, Eric

Germann, Nathalie

Pouget, Jean-Christophe

Plummer, Ruth

Vergote, Ignace

Thistlethwaite, Fiona

Bjarnason, Georg A.

Jones, Robert

Mackay, Helen

Edeline, Julien

Fartoux, Laetitia

Hirte, Hal

Oza, Amit
License Information

License valid from 2017-08-10